Review



drug h89  (Tocris)


Bioz Verified Symbol Tocris is a verified supplier
Bioz Manufacturer Symbol Tocris manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Tocris drug h89
    Drug H89, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 149 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h+89+dihydrochloride/H+89+dihydrochloride/pm41903111-159-13-15
    Average 95 stars, based on 149 article reviews
    drug h89 - by Bioz Stars, 2026-10
    95/100 stars

    Images

    Related Articles

    other:

    Article Title: Serotonin 5-HT 2C receptor as a cellular target of PI3K inhibitor LY294002 and its analog LY303511
    Article Snippet: LY294 (LY294002 hydrochloride) and LY303 (LY303511 hydrochloride) were from MedChemExpress; serotonin hydrochloride, insulin, m-3M3FBS, H-89 dihydrochloride, U73122, acetylcholine chloride, and RS-102221 hydrochloride were from Tocris Bioscience; wortmannin and ATP were from Sigma-Aldrich.

    Article Title: Ca V 1.2-dependent excitation-transcription coupling modulates nociception
    Article Snippet: Stock solutions were prepared as indicated in parentheses of the following compounds: Autocamtide-2 Related Inhibitory Peptide (AIP, Calbiochem, #189480, 500 μM in dH2O), (S)-(-)-Bay K 8644 (BayK, Alomone Labs, #B-351, 50 mM in DMSO), Capsaicin (Cap, Sigma-Aldrich, #M2028, 10 mM in DMSO), Cyclosporin A (CsA, Tocris, #1101, 50 mM in DMSO), H-89 Dihydrochloride (H89, Tocris, #2910, 25 mM in DMSO), KN93 (Tocris, #1278; 20 mM in DMSO), Nifedipine (Nife, Tocris, #1075, 10 mM in DMSO), Nimodipine (Nimo, Tocris, #0600, 10 mM in DMSO), STO-609 (Tocris, #1551, 10 mM in DMSO), U0126 (Calbiochem, #662005, 50 mM in DMSO), Verapamil (VP, Alomone Labs, #V-100, 100 mM stock in dH2O), Veratridine (VT, Alomone Labs; #V-110; 50 mM stock in DMSO), ω-agatoxin IVA (Alomone Labs, #STA-500, 200 μM stock in 0.1% BSA), ω-conotoxin GVIA (Alomone Labs, # C-300, 1 mM stock in 0.1% BSA), ω-conotoxin MVIIC (Alomone Labs, #C-150, 300 μM stock in 0.1% BSA).

    Article Title: Epinephrine inhibits PI3Kα via the Hippo kinases
    Article Snippet: H 89 dihydrochloride , Tocris Bioscience , Cat2910.

    Article Title: Epac2 in midbrain dopamine neurons contributes to cocaine reinforcement via enhancement of dopamine release
    Article Snippet: ESI-05, 6-Bnz-cAMP sodium salt, H-89 dihydrochloride were purchased from Tocris Bioscience (Minneapolis, MN).


    Isolation:

    Article Title: Thromboxane A2 or activated platelets slightly low-er Fgf23 expression in vitro.
    Article Snippet: After 24 h, cells were treated with or without 1-100 ng/ml of pinane thromboxane A2 (pTxA2; Cay19020-500; Biomol, Hamburg, Germany) [44], 1-100 ng/ml of the thromboxane A2 receptor (TxA2 receptor) agonist I-BOP (Cay19600-100; Biomol), and/or 1 μM of the TxA2 receptor antagonist SQ29548 (Cay19025-1; Biomol) for further 24 h in the presence of 10 nM calcitriol (1,25(OH)2D3, Tocris, Bio-Techne, Wiesbaden-Nordenstadt, Germany). .. In another series of experiments, UMR-106 cells were seeded in growth medium supplemented with 10 nM calcitriol, grown for 24 h and then additionally treated with 1-5 μM of thromboxane A2 receptor agonist U46619 (Cay16450-1; Biomol), 1-3 nM Serotonin hydrochloride (H9523-25MG; Sigma-Aldrich; Merck KGaA, Darmstadt; Germany), 0.3-10 μM adenosine diphosphate (ADP) (Cay21121-1; Biomol) or 50 nM H-89 dihydrochloride (2910; Tocris, Bio-Techne) for further 24 h. For co-culture experiments, UMR-106 cells were seeded in growth medium supplemented with 10 nM calcitriol, grown for 45 h, and then co-incubated with or without 100,000/μl freshly isolated platelets from human blood with or without additional 1 U/ml human thrombin (T6884-100N; Sigma-Aldrich) for further 3 h. MC3T3-E1 subclone 4 mouse pre-osteoblast cells (CRL-2593; ATCC) were cultured in proliferation medium consisting of α-minimum essential medium (αMEM) with 2 mM L-glutamine and nucleosides (Gibco, Life Technologies), 10% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin. ..

    Cell Culture:

    Article Title: Thromboxane A2 or activated platelets slightly low-er Fgf23 expression in vitro.
    Article Snippet: After 24 h, cells were treated with or without 1-100 ng/ml of pinane thromboxane A2 (pTxA2; Cay19020-500; Biomol, Hamburg, Germany) [44], 1-100 ng/ml of the thromboxane A2 receptor (TxA2 receptor) agonist I-BOP (Cay19600-100; Biomol), and/or 1 μM of the TxA2 receptor antagonist SQ29548 (Cay19025-1; Biomol) for further 24 h in the presence of 10 nM calcitriol (1,25(OH)2D3, Tocris, Bio-Techne, Wiesbaden-Nordenstadt, Germany). .. In another series of experiments, UMR-106 cells were seeded in growth medium supplemented with 10 nM calcitriol, grown for 24 h and then additionally treated with 1-5 μM of thromboxane A2 receptor agonist U46619 (Cay16450-1; Biomol), 1-3 nM Serotonin hydrochloride (H9523-25MG; Sigma-Aldrich; Merck KGaA, Darmstadt; Germany), 0.3-10 μM adenosine diphosphate (ADP) (Cay21121-1; Biomol) or 50 nM H-89 dihydrochloride (2910; Tocris, Bio-Techne) for further 24 h. For co-culture experiments, UMR-106 cells were seeded in growth medium supplemented with 10 nM calcitriol, grown for 45 h, and then co-incubated with or without 100,000/μl freshly isolated platelets from human blood with or without additional 1 U/ml human thrombin (T6884-100N; Sigma-Aldrich) for further 3 h. MC3T3-E1 subclone 4 mouse pre-osteoblast cells (CRL-2593; ATCC) were cultured in proliferation medium consisting of α-minimum essential medium (αMEM) with 2 mM L-glutamine and nucleosides (Gibco, Life Technologies), 10% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin. ..

    Inhibition:

    Article Title: Protective effect of pituitary adenylate cyclase activating polypeptide in diabetic keratopathy.
    Article Snippet: Diabetic keratopathy (DK) is the major complication of the cornea characterizing diabetes-affected patients.. This ocular pathology is correlated with the hyperglycemic state leading to delayed corneal wound healing and recurrent corneal ulcers.. Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide with widespread distribution throughout the body, and exerting cytoprotective effects in the neural and non-neuronal parts of the eye, including the cornea.



    Similar Products

    95
    MedChemExpress hy 15979a rapamycin sigma aldrich
    Hy 15979a Rapamycin Sigma Aldrich, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h+89+dihydrochloride/H-89+dihydrochloride/pm42532048-297-104-102
    Average 95 stars, based on 1 article reviews
    hy 15979a rapamycin sigma aldrich - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    97
    MedChemExpress h 89 dihydrochloride
    PIEZO1-dependent epithelial signaling regulates MMT via PKA/NF-κB P65 pathway. A Western blotting was performed to detect the phosphorylation level of AKT, ERK1/2, CREB, PKA and NF-κB P65 in THP-1 macrophages with CM for 24h (n = 5). P values were calculated using Student’s t-test. B Immunofluorescence showing the expression of CD68 + p-PKA + cells or CD68 + p-NF-κB P65 + cells in colonic mucosa between healthy controls and CD patients (n = 4). P values were calculated using Student’s t-test. C Endogenous interaction between PKA and NF-κB P65 in THP-1 macrophages. Co-immunoprecipitation (Co-IP) analysis demonstrating the physical association between PKA and P65. THP-1 macrophages were stimulated with CM from Caco-2 transfected with either shCTL or shPIEZO1. Lysates were immunoprecipitated (IP) with anti-PKA antibodies or an IgG isotype control, followed by immunoblotting (IB) with anti-PKA and anti-P65 antibodies. The presence of P65 in the PKA-IP fraction confirms the formation of the PKA/P65 complex. GAPDH was used as the loading control for Input lysates. D THP-1 macrophages were treated with CM derived from Caco-2-shCTL cells at 50% or 100% confluence (denoted as 50 and 100). For the 100 condition, cells were further transfected with siNC or siP65 as indicated. The protein expression of α-SMA, COL1A2 and NF-κB P65 were analyzed by Western blotting (n = 5). P values were calculated using one-way ANOVA and Tukey’s multiple comparisons test. E THP-1 macrophages were treated with CM derived from Caco-2-shCTL cells at 50% or 100% confluence (denoted as 50 and 100). For the 100 condition, cells were further treated with the PKA <t>inhibitor</t> <t>H-89</t> or NF-κB activator 1(activator-1), either alone or in combination, as indicated. Western blotting detected the expression of α-SMA, COL1A2 and the phosphorylation level of PKA and NF-κB P65 (n = 5). P values were calculated using one-way ANOVA and Tukey’s multiple comparisons test. Data are represented as mean ± SD, ****P<0.0001, ***P<0.001, **P<0.01, *P<0.05. Scale bar =50 μm. CM conditions are defined as in Fig.
    H 89 Dihydrochloride, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h+89+dihydrochloride/H-89/pmc13411382-48-33-35
    Average 97 stars, based on 1 article reviews
    h 89 dihydrochloride - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    95
    MedChemExpress thp 1 macrophages
    PIEZO1-dependent epithelial signaling regulates MMT via PKA/NF-κB P65 pathway. A Western blotting was performed to detect the phosphorylation level of AKT, ERK1/2, CREB, PKA and NF-κB P65 in THP-1 macrophages with CM for 24h (n = 5). P values were calculated using Student’s t-test. B Immunofluorescence showing the expression of CD68 + p-PKA + cells or CD68 + p-NF-κB P65 + cells in colonic mucosa between healthy controls and CD patients (n = 4). P values were calculated using Student’s t-test. C Endogenous interaction between PKA and NF-κB P65 in THP-1 macrophages. Co-immunoprecipitation (Co-IP) analysis demonstrating the physical association between PKA and P65. THP-1 macrophages were stimulated with CM from Caco-2 transfected with either shCTL or shPIEZO1. Lysates were immunoprecipitated (IP) with anti-PKA antibodies or an IgG isotype control, followed by immunoblotting (IB) with anti-PKA and anti-P65 antibodies. The presence of P65 in the PKA-IP fraction confirms the formation of the PKA/P65 complex. GAPDH was used as the loading control for Input lysates. D THP-1 macrophages were treated with CM derived from Caco-2-shCTL cells at 50% or 100% confluence (denoted as 50 and 100). For the 100 condition, cells were further transfected with siNC or siP65 as indicated. The protein expression of α-SMA, COL1A2 and NF-κB P65 were analyzed by Western blotting (n = 5). P values were calculated using one-way ANOVA and Tukey’s multiple comparisons test. E THP-1 macrophages were treated with CM derived from Caco-2-shCTL cells at 50% or 100% confluence (denoted as 50 and 100). For the 100 condition, cells were further treated with the PKA <t>inhibitor</t> <t>H-89</t> or NF-κB activator 1(activator-1), either alone or in combination, as indicated. Western blotting detected the expression of α-SMA, COL1A2 and the phosphorylation level of PKA and NF-κB P65 (n = 5). P values were calculated using one-way ANOVA and Tukey’s multiple comparisons test. Data are represented as mean ± SD, ****P<0.0001, ***P<0.001, **P<0.01, *P<0.05. Scale bar =50 μm. CM conditions are defined as in Fig.
    Thp 1 Macrophages, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h+89+dihydrochloride/H-89+dihydrochloride/pm42210253-51-18-29
    Average 95 stars, based on 1 article reviews
    thp 1 macrophages - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    MedChemExpress hy 15979a
    PIEZO1-dependent epithelial signaling regulates MMT via PKA/NF-κB P65 pathway. A Western blotting was performed to detect the phosphorylation level of AKT, ERK1/2, CREB, PKA and NF-κB P65 in THP-1 macrophages with CM for 24h (n = 5). P values were calculated using Student’s t-test. B Immunofluorescence showing the expression of CD68 + p-PKA + cells or CD68 + p-NF-κB P65 + cells in colonic mucosa between healthy controls and CD patients (n = 4). P values were calculated using Student’s t-test. C Endogenous interaction between PKA and NF-κB P65 in THP-1 macrophages. Co-immunoprecipitation (Co-IP) analysis demonstrating the physical association between PKA and P65. THP-1 macrophages were stimulated with CM from Caco-2 transfected with either shCTL or shPIEZO1. Lysates were immunoprecipitated (IP) with anti-PKA antibodies or an IgG isotype control, followed by immunoblotting (IB) with anti-PKA and anti-P65 antibodies. The presence of P65 in the PKA-IP fraction confirms the formation of the PKA/P65 complex. GAPDH was used as the loading control for Input lysates. D THP-1 macrophages were treated with CM derived from Caco-2-shCTL cells at 50% or 100% confluence (denoted as 50 and 100). For the 100 condition, cells were further transfected with siNC or siP65 as indicated. The protein expression of α-SMA, COL1A2 and NF-κB P65 were analyzed by Western blotting (n = 5). P values were calculated using one-way ANOVA and Tukey’s multiple comparisons test. E THP-1 macrophages were treated with CM derived from Caco-2-shCTL cells at 50% or 100% confluence (denoted as 50 and 100). For the 100 condition, cells were further treated with the PKA <t>inhibitor</t> <t>H-89</t> or NF-κB activator 1(activator-1), either alone or in combination, as indicated. Western blotting detected the expression of α-SMA, COL1A2 and the phosphorylation level of PKA and NF-κB P65 (n = 5). P values were calculated using one-way ANOVA and Tukey’s multiple comparisons test. Data are represented as mean ± SD, ****P<0.0001, ***P<0.001, **P<0.01, *P<0.05. Scale bar =50 μm. CM conditions are defined as in Fig.
    Hy 15979a, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h+89+dihydrochloride/H-89+dihydrochloride/pmc13156568-28-5-2
    Average 95 stars, based on 1 article reviews
    hy 15979a - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    MedChemExpress h89
    The conformational, dynamic, and kinetic differences between BLU0588 ( A ) and <t>H89</t> ( B ). Left panels: Comparison of the PKA-C B-factor dynamics when bound to the respective inhibitor. Middle panels: Inhibitor-bound active site interactions and occupation of each PKA-C subsite. Right panels: SPR sensorgrams show the inhibitor’s association and dissociation for BLU0588 and for H89 using a concentration series of the respective inhibitors interacting with captured FSS-tagged PKA-C. Dashed lines are fits to determine the respective rate constants (k ass and k diss ) and the experimental R max for both inhibitors. Representative experiment of n = 2 experimental setups.
    H89, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h+89+dihydrochloride/H-89+dihydrochloride/pmc13167742-226-6-7
    Average 95 stars, based on 1 article reviews
    h89 - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    Tocris drug h89
    The conformational, dynamic, and kinetic differences between BLU0588 ( A ) and <t>H89</t> ( B ). Left panels: Comparison of the PKA-C B-factor dynamics when bound to the respective inhibitor. Middle panels: Inhibitor-bound active site interactions and occupation of each PKA-C subsite. Right panels: SPR sensorgrams show the inhibitor’s association and dissociation for BLU0588 and for H89 using a concentration series of the respective inhibitors interacting with captured FSS-tagged PKA-C. Dashed lines are fits to determine the respective rate constants (k ass and k diss ) and the experimental R max for both inhibitors. Representative experiment of n = 2 experimental setups.
    Drug H89, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h+89+dihydrochloride/H+89+dihydrochloride/pm41903111-159-13-15
    Average 95 stars, based on 1 article reviews
    drug h89 - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    Tocris h89 tocris
    The conformational, dynamic, and kinetic differences between BLU0588 ( A ) and <t>H89</t> ( B ). Left panels: Comparison of the PKA-C B-factor dynamics when bound to the respective inhibitor. Middle panels: Inhibitor-bound active site interactions and occupation of each PKA-C subsite. Right panels: SPR sensorgrams show the inhibitor’s association and dissociation for BLU0588 and for H89 using a concentration series of the respective inhibitors interacting with captured FSS-tagged PKA-C. Dashed lines are fits to determine the respective rate constants (k ass and k diss ) and the experimental R max for both inhibitors. Representative experiment of n = 2 experimental setups.
    H89 Tocris, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h+89+dihydrochloride/H+89+dihydrochloride/pm41903111-517-60-61
    Average 95 stars, based on 1 article reviews
    h89 tocris - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    h89  (Tocris)
    95
    Tocris h89
    The conformational, dynamic, and kinetic differences between BLU0588 ( A ) and <t>H89</t> ( B ). Left panels: Comparison of the PKA-C B-factor dynamics when bound to the respective inhibitor. Middle panels: Inhibitor-bound active site interactions and occupation of each PKA-C subsite. Right panels: SPR sensorgrams show the inhibitor’s association and dissociation for BLU0588 and for H89 using a concentration series of the respective inhibitors interacting with captured FSS-tagged PKA-C. Dashed lines are fits to determine the respective rate constants (k ass and k diss ) and the experimental R max for both inhibitors. Representative experiment of n = 2 experimental setups.
    H89, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h+89+dihydrochloride/H+89+dihydrochloride/pm41812870-311-2-3
    Average 95 stars, based on 1 article reviews
    h89 - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc pka inhibitor h89
    The conformational, dynamic, and kinetic differences between BLU0588 ( A ) and <t>H89</t> ( B ). Left panels: Comparison of the PKA-C B-factor dynamics when bound to the respective inhibitor. Middle panels: Inhibitor-bound active site interactions and occupation of each PKA-C subsite. Right panels: SPR sensorgrams show the inhibitor’s association and dissociation for BLU0588 and for H89 using a concentration series of the respective inhibitors interacting with captured FSS-tagged PKA-C. Dashed lines are fits to determine the respective rate constants (k ass and k diss ) and the experimental R max for both inhibitors. Representative experiment of n = 2 experimental setups.
    Pka Inhibitor H89, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h+89+dihydrochloride/H-89%2C+Dihydrochloride/pm41741641-639-44-47
    Average 93 stars, based on 1 article reviews
    pka inhibitor h89 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    95
    MedChemExpress pka inhibitor
    The conformational, dynamic, and kinetic differences between BLU0588 ( A ) and <t>H89</t> ( B ). Left panels: Comparison of the PKA-C B-factor dynamics when bound to the respective inhibitor. Middle panels: Inhibitor-bound active site interactions and occupation of each PKA-C subsite. Right panels: SPR sensorgrams show the inhibitor’s association and dissociation for BLU0588 and for H89 using a concentration series of the respective inhibitors interacting with captured FSS-tagged PKA-C. Dashed lines are fits to determine the respective rate constants (k ass and k diss ) and the experimental R max for both inhibitors. Representative experiment of n = 2 experimental setups.
    Pka Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/h+89+dihydrochloride/H-89+dihydrochloride/pm41724283-45-10-17
    Average 95 stars, based on 1 article reviews
    pka inhibitor - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    Image Search Results


    PIEZO1-dependent epithelial signaling regulates MMT via PKA/NF-κB P65 pathway. A Western blotting was performed to detect the phosphorylation level of AKT, ERK1/2, CREB, PKA and NF-κB P65 in THP-1 macrophages with CM for 24h (n = 5). P values were calculated using Student’s t-test. B Immunofluorescence showing the expression of CD68 + p-PKA + cells or CD68 + p-NF-κB P65 + cells in colonic mucosa between healthy controls and CD patients (n = 4). P values were calculated using Student’s t-test. C Endogenous interaction between PKA and NF-κB P65 in THP-1 macrophages. Co-immunoprecipitation (Co-IP) analysis demonstrating the physical association between PKA and P65. THP-1 macrophages were stimulated with CM from Caco-2 transfected with either shCTL or shPIEZO1. Lysates were immunoprecipitated (IP) with anti-PKA antibodies or an IgG isotype control, followed by immunoblotting (IB) with anti-PKA and anti-P65 antibodies. The presence of P65 in the PKA-IP fraction confirms the formation of the PKA/P65 complex. GAPDH was used as the loading control for Input lysates. D THP-1 macrophages were treated with CM derived from Caco-2-shCTL cells at 50% or 100% confluence (denoted as 50 and 100). For the 100 condition, cells were further transfected with siNC or siP65 as indicated. The protein expression of α-SMA, COL1A2 and NF-κB P65 were analyzed by Western blotting (n = 5). P values were calculated using one-way ANOVA and Tukey’s multiple comparisons test. E THP-1 macrophages were treated with CM derived from Caco-2-shCTL cells at 50% or 100% confluence (denoted as 50 and 100). For the 100 condition, cells were further treated with the PKA inhibitor H-89 or NF-κB activator 1(activator-1), either alone or in combination, as indicated. Western blotting detected the expression of α-SMA, COL1A2 and the phosphorylation level of PKA and NF-κB P65 (n = 5). P values were calculated using one-way ANOVA and Tukey’s multiple comparisons test. Data are represented as mean ± SD, ****P<0.0001, ***P<0.001, **P<0.01, *P<0.05. Scale bar =50 μm. CM conditions are defined as in Fig.

    Journal: Cell Communication and Signaling : CCS

    Article Title: Intestinal epithelial PIEZO1 regulates macrophage-to-myofibroblast transition via epithelial-derived TGF-α signaling in Crohn’s disease

    doi: 10.1186/s12964-026-02941-w

    Figure Lengend Snippet: PIEZO1-dependent epithelial signaling regulates MMT via PKA/NF-κB P65 pathway. A Western blotting was performed to detect the phosphorylation level of AKT, ERK1/2, CREB, PKA and NF-κB P65 in THP-1 macrophages with CM for 24h (n = 5). P values were calculated using Student’s t-test. B Immunofluorescence showing the expression of CD68 + p-PKA + cells or CD68 + p-NF-κB P65 + cells in colonic mucosa between healthy controls and CD patients (n = 4). P values were calculated using Student’s t-test. C Endogenous interaction between PKA and NF-κB P65 in THP-1 macrophages. Co-immunoprecipitation (Co-IP) analysis demonstrating the physical association between PKA and P65. THP-1 macrophages were stimulated with CM from Caco-2 transfected with either shCTL or shPIEZO1. Lysates were immunoprecipitated (IP) with anti-PKA antibodies or an IgG isotype control, followed by immunoblotting (IB) with anti-PKA and anti-P65 antibodies. The presence of P65 in the PKA-IP fraction confirms the formation of the PKA/P65 complex. GAPDH was used as the loading control for Input lysates. D THP-1 macrophages were treated with CM derived from Caco-2-shCTL cells at 50% or 100% confluence (denoted as 50 and 100). For the 100 condition, cells were further transfected with siNC or siP65 as indicated. The protein expression of α-SMA, COL1A2 and NF-κB P65 were analyzed by Western blotting (n = 5). P values were calculated using one-way ANOVA and Tukey’s multiple comparisons test. E THP-1 macrophages were treated with CM derived from Caco-2-shCTL cells at 50% or 100% confluence (denoted as 50 and 100). For the 100 condition, cells were further treated with the PKA inhibitor H-89 or NF-κB activator 1(activator-1), either alone or in combination, as indicated. Western blotting detected the expression of α-SMA, COL1A2 and the phosphorylation level of PKA and NF-κB P65 (n = 5). P values were calculated using one-way ANOVA and Tukey’s multiple comparisons test. Data are represented as mean ± SD, ****P<0.0001, ***P<0.001, **P<0.01, *P<0.05. Scale bar =50 μm. CM conditions are defined as in Fig.

    Article Snippet: Differentiated THP-1 macrophages were then treated with CM collected from Caco-2-shPIEZO1 (KD) or Caco-2-shCTL (CTL) cells for 24 h. In the PKA inhibition experiment, THP-1 macrophages were treated with CM with or without H-89 dihydrochloride (MedChemExpress, USA; Cat. # HY-15979 A) (30 nmol/L) for 24 h. In the NF-κΒ P65 activation experiment, THP-1 macrophages were stimulated with CM with or without NF-κΒ activator 1 (Selleck Chemicals, USA; Cat. # E1351) (9 nmol/L) for 24 h.

    Techniques: Western Blot, Phospho-proteomics, Immunofluorescence, Expressing, Immunoprecipitation, Co-Immunoprecipitation Assay, Transfection, Control, Derivative Assay

    The conformational, dynamic, and kinetic differences between BLU0588 ( A ) and H89 ( B ). Left panels: Comparison of the PKA-C B-factor dynamics when bound to the respective inhibitor. Middle panels: Inhibitor-bound active site interactions and occupation of each PKA-C subsite. Right panels: SPR sensorgrams show the inhibitor’s association and dissociation for BLU0588 and for H89 using a concentration series of the respective inhibitors interacting with captured FSS-tagged PKA-C. Dashed lines are fits to determine the respective rate constants (k ass and k diss ) and the experimental R max for both inhibitors. Representative experiment of n = 2 experimental setups.

    Journal: Proceedings of the National Academy of Sciences of the United States of America

    Article Title: A PKA-selective inhibitor captures an open but more ordered conformation of the PKA catalytic subunit

    doi: 10.1073/pnas.2536312123

    Figure Lengend Snippet: The conformational, dynamic, and kinetic differences between BLU0588 ( A ) and H89 ( B ). Left panels: Comparison of the PKA-C B-factor dynamics when bound to the respective inhibitor. Middle panels: Inhibitor-bound active site interactions and occupation of each PKA-C subsite. Right panels: SPR sensorgrams show the inhibitor’s association and dissociation for BLU0588 and for H89 using a concentration series of the respective inhibitors interacting with captured FSS-tagged PKA-C. Dashed lines are fits to determine the respective rate constants (k ass and k diss ) and the experimental R max for both inhibitors. Representative experiment of n = 2 experimental setups.

    Article Snippet: BLU0588 (MedChemExpress, CAS No.: 2810474-78-3) and H89 (MedChemExpress, CAS No.: 130964-39-5) were dissolved in DMSO and stored as a 10 mM stock solution at −80 °C until use.

    Techniques: Comparison, Concentration Assay